Landa, Alkent .

HRN: 28-68-62  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/10/2026
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
03/10/2026
03/17/2026
IV
230mg
Q6h
PCAP-C
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: